Uttam Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 1.67 M
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 15.57 Cr
About Uttam Pharma Labs
Uttam Pharma Labs Private Limited (UPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 1995 and has a history of 29 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 1.67 M.
The company currently has active open charges totaling ₹15.57 Cr.
Malti Shah and Ravindra Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1995PTC091890
- Company No.
091890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1995
- Date of AGM
30 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Uttam Pharma Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malti Shah  | Director | 17-Aug-1995 | Current |
| Ravindra Shah | Director | 17-Aug-1995 | Current |
Financial Performance of Uttam Pharma Labs.
Enhance accessibility to Uttam Pharma Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Uttam Pharma Labs?
Unlock access to Uttam Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹155.73 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 12.90 Cr
- Allahabad Bank : 1.60 Cr
- Bank Of India : 1.02 Cr
- Sundaram Finance Ltd. : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2008 | State Bank Of India | ₹8.00 Cr | Open |
| 13 Feb 2006 | State Bank Of India | ₹4.90 Cr | Open |
| 08 Nov 2005 | Allahabad Bank | ₹1.60 Cr | Open |
| 05 Nov 2005 | Bank Of India | ₹2.00 M | Open |
| 24 Jun 2005 | Sundaram Finance Ltd. | ₹0.53 M | Open |
How Many Employees Work at Uttam Pharma Labs?
Unlock and access historical data on people associated with Uttam Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uttam Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttam Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.